Approaching the degradome in idiopathic pulmonary fibrosis.
about
Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood instituteMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersRole of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosisMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisPotential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosisMMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosisLigand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansMicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosisMolecular pathogenesis of infections caused by Legionella pneumophilaLung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.A review of current and novel therapies for idiopathic pulmonary fibrosisInhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosisComparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.Fibrocytes and the tissue niche in lung repair.A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2Meprin β contributes to collagen deposition in lung fibrosis.Interplay of extracellular matrix and leukocytes in lung inflammation.Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption.Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.Associations of MMP-7 and OPN gene polymorphisms with risk of coal workers' pneumoconiosis in a Chinese population: a case-control study.Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.Role of matrix metaloproteases in idiopathic pulmonary fibrosis.Regulatory effect of caffeic acid phenethyl ester on type I collagen and interferon-gamma in bleomycin-induced pulmonary fibrosis in rat.Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.Endogenous lung regeneration: potential and limitations.Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.Fibrosis: Lessons from OMICS analyses of the human lung.Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis.Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosisSequential changes of serum KL-6 predict the progression of interstitial lung disease
P2860
Q26852563-C03B4C55-88CA-4FB0-A38E-FE81D6243B0FQ26864836-B6D35D45-E1DD-4ADE-A7E0-2DD2428E6079Q28069417-40CE3E48-FFD9-483E-AE33-7F36BF8EDDEDQ28386047-0113FD44-BFC1-443D-8C62-51AEEA89ED79Q28389128-71D8D182-B8FF-42CB-9921-C153F65686DCQ28472658-80E0573D-98D5-45A5-A53E-C4F21928E1E8Q33576663-5F7942DD-1E92-4C38-A868-390C5C32EEFDQ33745690-31ACB3BB-C76D-462C-BD30-174369FB7670Q33799699-FCEBB560-B0F3-4AF5-A51D-E04A7CE59F99Q33825611-B5AC6861-715F-48DC-A451-F1BB203205A8Q34010640-CF365D3E-2973-4900-98C1-D15A5FB98AD6Q34354002-E1BB159F-C24A-45CD-81CB-BD9B968550C5Q34984345-E2D5199E-51F9-43F9-9FFD-E9491C201F62Q35077927-BF543D64-25B9-4D48-BBAC-94ADB2DF21CCQ35078509-557CA461-3BB8-46CA-8BA9-CE0334A1100CQ36095068-19AD411D-02C4-4209-8B00-7D8C953B2203Q36251710-41322DCF-F79A-4E52-9EFE-7BE906066896Q36542274-F8E3D3D2-E7E9-43EC-956B-6BF910300E7CQ36638211-DF821989-8AA1-4522-9EA6-842FB61C733DQ36949126-1942AA21-2120-4230-8D2E-47F4365970C3Q37688507-5D5DE8E6-1DCE-484C-A956-8093E98D6342Q37887074-4B443AF1-2E0D-4875-8CBE-735D9B93A8B3Q38473170-A908AD85-645A-4E31-BF77-2D17ACAC2945Q38775556-A1C6B2F7-7F89-4565-9AED-E24FAB4BC215Q39036654-9EF73608-CCF9-4D32-B301-7CF2D7E17148Q39080263-3337CE0F-4A02-4D07-A5D3-AFA3DD97DCE0Q39117478-8DD47538-50A9-4045-9578-DB5969661E09Q39673967-4477E8EE-13D7-4FD5-8503-F59B6B951D62Q41432498-BA436790-2E4D-4DDC-B0D0-75B344BC639FQ41703248-6DD8564A-5698-43CC-845B-4F3B4F261C8CQ42185529-35781D6A-1CA2-441C-9261-EAD376CF2B4CQ42577206-203C1848-8895-4CC6-BE9C-39730AB02C35Q43061664-23663005-803F-4266-9DC4-2FCACFE6A512Q46210244-2CE744B4-0D96-482B-857F-43F6FA16B9AFQ47163822-D42602F7-C849-4B04-B7D9-9AA58DBA1801Q51760494-09DF502E-8DEF-44A3-B8C0-1C259593C916Q52578942-CA15917E-8E0B-4BB7-814E-F6039C786208Q58747855-284A05A6-C2A9-49F0-92D6-E096562C0213Q58804483-A27DCC6B-EC2E-4A47-B847-A972D1818B31
P2860
Approaching the degradome in idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Approaching the degradome in idiopathic pulmonary fibrosis.
@en
Approaching the degradome in idiopathic pulmonary fibrosis.
@nl
type
label
Approaching the degradome in idiopathic pulmonary fibrosis.
@en
Approaching the degradome in idiopathic pulmonary fibrosis.
@nl
prefLabel
Approaching the degradome in idiopathic pulmonary fibrosis.
@en
Approaching the degradome in idiopathic pulmonary fibrosis.
@nl
P1476
Approaching the degradome in idiopathic pulmonary fibrosis.
@en
P2093
Annie Pardo
Moisés Selman
P304
P356
10.1016/J.BIOCEL.2007.11.020
P577
2007-12-08T00:00:00Z